Clinical Nurse Specialist in Manhasset, NY Accepting Medicare

4 Clinical Nurse Specialist nurses found. Showing 1 - 4

Libia Rosa Fonseca, NP Clinical Nurse Specialist - Acute Care Medicare: Medicare Enrolled Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 786-380-0816

Donna Kerner, Clinical Nurse Specialist - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-353-4157

Eun Ryang Jang, Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr., North Shore University Hospital, Manhasset, NY 11030 Phone: 516-562-4125

Mrs. Jincy Varghese Mammen, NP Clinical Nurse Specialist - Family Health Medicare: Accepting Medicare Assignments Practice Location: 600 Community Dr, Manhasset, NY 11030 Phone: 516-734-7000

News Archive

Arrowhead receives approval to initiate Phase 2a clinical trial of ARC-520 for chronic HBV infection

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.

New classification system for periodontal health, diseases and conditions announced at EuroPerio9 congress

A new global classification system for periodontal health, diseases and conditions, as well as peri-implant diseases and conditions, has been announced today at the EuroPerio9 congress, the world's leading congress in periodontology and implant dentistry.

Alnylam Pharmaceuticals presents new data on ALN-TTR01 RNAi therapeutic at amyloidosis symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new pre-clinical data from its ALN-TTR program at the XII International Symposium on Amyloidosis in Rome on April 18 - 21, 2010. ALN-TTR01 is a systemically delivered RNAi therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), including familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy (FAC).

Researchers uncover specific microbial signatures of intestinal disease

Researchers from the Department of Biomedical Research of the University of Bern and the University Clinic of Visceral Surgery and Medicine of the Inselspital Bern, Switzerland, have discovered that changes in the composition of the intestinal bacteria in patients with chronic inflammatory bowel disease affect the severity of the disease and the success of therapy.

Read more Medical News

› Verified 3 days ago